T. Rowe Price Associates’s Aravive, Inc. Common Stock ARAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-5,527
Closed -$73K 2595
2017
Q4
$73K Hold
5,527
﹤0.01% 2533
2017
Q3
$81K Hold
5,527
﹤0.01% 2518
2017
Q2
$579K Hold
5,527
﹤0.01% 1999
2017
Q1
$708K Buy
+5,527
New +$583K ﹤0.01% 1928
2015
Q2
Sell
-146,533
Closed -$16.2M 2564
2015
Q1
$16.2M Buy
146,533
+75,416
+106% +$8.85M ﹤0.01% 1190
2014
Q4
$9.58M Sell
71,117
-1,050
-1% -$123K ﹤0.01% 1337
2014
Q3
$8.22M Buy
72,167
+27,584
+62% +$3.66M ﹤0.01% 1357
2014
Q2
$7.5M Buy
+44,583
New +$7.69M ﹤0.01% 1376

Other funds holding ARAV

T. Rowe Price Associates's ARAV Position: Q1 2018 in Review

T. Rowe Price Associates sold out of Aravive, Inc. Common Stock (ARAV) in Q1 2018, closing a stake of 5,527 shares — an estimated $73K sold.

T. Rowe Price Associates first reported a position in ARAV in Q2 2014 and held it in 8 quarters. The position peaked at $16.2M in Q1 2015. 69 funds tracked by Wall St. Rank hold ARAV as of Q1 2018.

  • T. Rowe Price Associates reported no remaining Aravive, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • T. Rowe Price Associates sold 5,527 Aravive, Inc. Common Stock shares in Q1 2018, an estimated $73K.
  • T. Rowe Price Associates first reported a position in Aravive, Inc. Common Stock in Q2 2014 and held it in 8 quarters.
  • T. Rowe Price Associates's Aravive, Inc. Common Stock position peaked at $16.2M in Q1 2015.
  • 69 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q1 2018.

Based on T. Rowe Price Associates's 13F filing for Q1 2018, filed 14 May 2018.